In the original publication [...].
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452336 | PMC |
http://dx.doi.org/10.3390/biology12081112 | DOI Listing |
Biology (Basel)
August 2023
Department of Molecular and Genomic Biomedicine, School of Biomedical Sciences, Nagasaki University Graduate, Nagasaki 852-8523, Japan.
Int J Mol Sci
May 2021
Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Front Immunol
November 2017
Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, United States.
[This corrects the article on p. 2 in vol. 7, PMID: 26834744.
View Article and Find Full Text PDFBioData Min
April 2016
Leidos BioMedical Research, Inc., Frederick National Laboratory for Cancer Research, NIH, Frederick, MD USA.
J Data Mining Genomics Proteomics
July 2013
Laboratory of Immunopathogenesis and Bioinformatics, SAIC-Frederick, Inc., Frederick National Laboratory, MD 21702, USA.
PacBio RS, a newly emerging third-generation DNA sequencing platform, is based on a real-time, single-molecule, nano-nitch sequencing technology that can generate very long reads (up to 20-kb) in contrast to the shorter reads produced by the first and second generation sequencing technologies. As a new platform, it is important to assess the sequencing error rate, as well as the quality control (QC) parameters associated with the PacBio sequence data. In this study, a mixture of 10 prior known, closely related DNA amplicons were sequenced using the PacBio RS sequencing platform.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!